Systematic review and meta-analysis explores the prognosis, epidemiology, and treatment of aplastic anaemia.
Background: 6p copy number loss of heterozygosity (6pLOH) and human leukocyte antigen-inactivating mutations (HLA-IAs) can “rule in” a diagnosis of immune aplastic anaemia (iAA). We conducted a scoping systematic review (SR) and meta-analysis (MA) to determine availability of published data on epidemiology, prognosis, and impact on treatment.
No takes yet. Share an insight, caveat, or question.
Lucas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: